Kurolap A et al.Eculizumab is safe and effective as a long-term treatment for protein-losing enteropathy due to CD55-deficiency.J Pediatr Gastroenterol Nutr. 2018. PMID: 30418410.
Kurolap A et al.Loss of CD55 in Eculizumab-Responsive Protein-Losing Enteropathy. N Engl J Med. 2017;377(1):87-89. PMID: 28657861.
Ozen A et al.CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. N Engl J Med. 2017;377(1):52-61. PMID: 28657829.